US DONATES 10 MILLION ADDITIONAL PFIZER VACCINE TO PAKISTAN

0
77

ISLAMABAD, OCT 15 (DNA) – The United States is shipping an additional 9.6 million doses of Pfizer COVID-19 vaccines through the COVAX facility to Pakistan.  This donation brings the total number of COVID-19 vaccines donated by the U.S. government to the Pakistani people to more than 25 million.

These Pfizer vaccines are part of the 500 million Pfizer doses the United States purchased this summer to deliver to 92 countries worldwide, including Pakistan, to fulfill President Biden’s commitment to provide safe and effective vaccines around the world and supercharge the global fight against the pandemic.  At the virtual Global COVID-19 Summit held on the margins of the UN General Assembly in September, President Biden announced the United States will provide an additional 500 million Pfizer vaccines to low and lower-middle income countries around the globe, with shipments starting in January 2022.

“The United States is proud to partner with Pakistan to get effective, life-saving Pfizer vaccinations into the arms of Pakistanis, and Pakistan has done a great job of distributing our donated vaccines,” said U.S. Embassy Chargé d’affaires Angela P. Aggeler.  “This donation comes just in time for young Pakistanis over age 12 to get their first jabs.  Please get vaccinated and take a selfie using one of our “I Got Vaccinated” photo booth frames.  You can find them at the Mass Vaccination Clinic in F-9 and at several of our Lincoln Corners.  And be sure to tag @usembislamabad when you take your selfie!”

The United States has also delivered $63 million in COVID-19 assistance through our partnership with the Government of Pakistan.  Since the start of the pandemic, the United States has worked together with Pakistan to improve infection prevention and control, enhance patient care, expand laboratory testing, and support frontline healthcare workers.

The United States is the single largest contributor supporting COVAX efforts toward global COVID-19 vaccines access.